Zogenix has manufactured and shipped over 2,000,000 commercial DosePro units. DosePro needle-free delivery system is currently being co-marketed with Battelle, the world's largest independent research and development organization, to potential biopharmaceutical and government clients. The companies have embarked on a "Less is More" campaign that aims to showcase the simplicity and benefits of the DosePro technology and its ability to provide instantaneous, needle-free, subcutaneous drug delivery.For more information on the DosePro needle-free delivery system, please visit www.DosePro.com .
Zogenix To Present New Case Study Highlighting Successful Repositioning Of Injectable Sumatriptan For Migraine With A Novel Needle-Free Delivery Technology
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.